Results 251 to 260 of about 90,167 (303)

Static and Dynamic Balance Is Impaired in Patients With Long‐Term, Well‐Controlled Acromegaly: A Cross‐Sectional Study

open access: yesClinical Endocrinology, Volume 103, Issue 5, Page 703-710, November 2025.
ABSTRACT Objective Balance impairment is an underrecognized complication of acromegaly with potentially serious consequences for affected patients. In this study, we aimed to assess the balance in patients with long‐term acromegaly compared to non‐acromegalic controls. Design Cross‐sectional study.
Christian Rosendal   +4 more
wiley   +1 more source

What are mice teaching us about psoriatic arthritis? [PDF]

open access: yesCurr Opin Rheumatol
Randon PM, Gudjonsson JE, Ward NL.
europepmc   +1 more source

Effectiveness of Bimekizumab in Psoriatic Arthritis: A Multicenter Real‐Life Study With Clinical and Ultrasound Evaluation in the Lazio Region, Italy

open access: yesInternational Journal of Dermatology, Volume 64, Issue 11, Page 2038-2044, November 2025.
ABSTRACT Background Bimekizumab, a monoclonal antibody targeting interleukin (IL)‐17A and IL‐17F, has shown efficacy in psoriatic arthritis (PsA) clinical trials, but real‐world data on its effectiveness are limited. This study aimed to evaluate its real‐world effectiveness in PsA patients treated in dermatologic settings.
Giacomo Caldarola   +12 more
wiley   +1 more source

Identification of Disulfidptosis‐Associated Hub Genes in Psoriasis via Integrated Transcriptomic and Experimental Validation Approaches

open access: yesJournal of Cellular and Molecular Medicine, Volume 29, Issue 21, November 2025.
ABSTRACT Psoriasis is a chronic, immune‐mediated skin disease. While redox imbalance has been implicated in its pathogenesis, the involvement of newly identified cell death pathways remains unclear. Disulfidptosis, a novel form of regulated cell death driven by intracellular disulfide stress, has recently been linked to inflammatory and metabolic ...
Siyu Liu   +6 more
wiley   +1 more source

Association between glucose intolerance and psoriatic arthritis features. [PDF]

open access: yesRMD Open
Mehta S   +6 more
europepmc   +1 more source

Systemic treatment of immune checkpoint inhibitor‐induced psoriasis: Inference‐based guidance

open access: yesJournal of the European Academy of Dermatology and Venereology, Volume 39, Issue 11, Page 1881-1894, November 2025.
When managing psoriasis, induced or exacerbated by ICI therapy for cancer, there are concerns regarding immunosuppression from systemic agents for the treatment of psoriasis and the potential impact on ICI efficacy. No direct, high‐level evidence exists to address these concerns.
Kim A. Papp   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy